In -cells, it shows **cAMP-preferred (vs -arrestin)** signalinghypothesized to support sustained metabolic signaling (clinical significance still evolving)
Most people start with 1.5 mg for about 30 days, bump to 4 mg, and if needed, go to 9 mg
GLP-1 dispensing among adolescents, young adults rose from 2020 to 2023 Key takeaways: GLP-1 receptor agonist dispensing increased 659.4% among young women and 587.5% among adolescent girls
When the body produces insufficient digestive enzymes, a condition known as exocrine pancreatic insufficiency may develop, leading to malabsorption, bloating, diarrhoea, and nutritional deficiencies
GPR119 small molecule agonist, AR231453, was purchased from Sigma (Dorset, U.K.) and glucagon receptor (GCGR) small molecule antagonist, L-168049 was purchased from Tocris (Bristol, U.K.)